Trial intelligence / Profile preview

Mirabegron Combined With Behavioral Intervention for Overactive Bladder

NCT05452434Phase 4Unknown

Sponsor
Peking Union Medical College Hospital
Start
Jul 2022
Primary completion
Jul 2023
Modality
Small Molecules
01

Overview

A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

mirabegron
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on NCT05452434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05452434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call